The Mechanics of the Tech Transfer Narrative during COVID-19
Newsletter Edition #74 [The Friday Deep Dives]
Ever so often, it is important to take a step back to reflect on the bigger picture. This week, we examine the recent discussions on technology transfer in the context of making COVID-19 medical products available.
The story also puts in perspective the Pfizer/BioNTech deal with South Africa’s Biovac announced this week.
We hope you like this analy…
Keep reading with a 7-day free trial
Subscribe to Geneva Health Files to keep reading this post and get 7 days of free access to the full post archives.